Iqvia Holdings (IQV) Net Cash Flow Growth (3y) (2015 - 2026)
Iqvia Holdings (IQV) Net Cash Flow Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.74 Bn | 209.68 Bn | 8.34 Bn | 58.74% |
| 2 | Danaher | 140.25 Bn | 135.90 Bn | 3.61 Bn | -43.12% |
| 3 | Idexx Laboratories | 46.19 Bn | 46.00 Bn | 779.09 Mn | -29.30% |
| 4 | Agilent Technologies | 39.75 Bn | 37.94 Bn | 990.00 Mn | 41.14% |
| 5 | Iqvia Holdings | 39.35 Bn | 37.27 Bn | 1.44 Bn | 27.97% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 29.81% |
| 7 | Illumina | 30.03 Bn | 28.86 Bn | 770.00 Mn | -40.43% |
| 8 | Mettler Toledo International | 28.64 Bn | 28.59 Bn | 650.22 Mn | -38.01% |
| 9 | Quest Diagnostics | 26.16 Bn | 25.54 Bn | 1.03 Bn | 89.23% |
| 10 | Labcorp Holdings | 25.86 Bn | 24.88 Bn | 1.01 Bn | 138.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.97% |
| Mar 31, 2026 | -26.81% |
| Dec 31, 2025 | 51.96% |
| Sep 30, 2025 | -26.79% |
| Jun 30, 2025 | 33.81% |
| Mar 31, 2025 | -49.58% |
| Dec 31, 2024 | 60.71% |
| Sep 30, 2024 | 63.83% |
| Jun 30, 2024 | 30.26% |
| Mar 31, 2024 | -42.01% |
| Dec 31, 2023 | -28.60% |
| Sep 30, 2023 | -34.00% |
| Jun 30, 2023 | -36.62% |
| Mar 31, 2023 | 32.95% |
| Dec 31, 2022 | -40.10% |
| Sep 30, 2022 | -50.18% |
| Jun 30, 2022 | 200.92% |
| Mar 31, 2022 | 14.47% |
| Dec 31, 2021 | -46.56% |
| Sep 30, 2021 | -101.06% |